176 related articles for article (PubMed ID: 21182840)
1. In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells.
Zuleger CL; Macklin MD; Bostwick BL; Pei Q; Newton MA; Albertini MR
J Immunol Methods; 2011 Feb; 365(1-2):76-86. PubMed ID: 21182840
[TBL] [Abstract][Full Text] [Related]
2. Clonal expansions of 6-thioguanine resistant T lymphocytes in the blood and tumor of melanoma patients.
Albertini MR; Macklin MD; Zuleger CL; Newton MA; Judice SA; Albertini RJ
Environ Mol Mutagen; 2008 Dec; 49(9):676-87. PubMed ID: 18712786
[TBL] [Abstract][Full Text] [Related]
3. In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients.
Albertini MR; King DM; Newton MA; Vacek PM
Mutat Res; 2001 May; 476(1-2):83-97. PubMed ID: 11336986
[TBL] [Abstract][Full Text] [Related]
4. Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.
Serana F; Sottini A; Caimi L; Palermo B; Natali PG; Nisticò P; Imberti L
J Transl Med; 2009 Mar; 7():21. PubMed ID: 19317896
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
6. Coamplification of hprt cDNA and gamma T-cell receptor sequences from 6-thioguanine resistant human T-lymphocytes.
Curry J; Skandalis A; Holcroft J; de Boer J; Glickman B
Mutat Res; 1993 Aug; 288(2):269-75. PubMed ID: 7688087
[TBL] [Abstract][Full Text] [Related]
7. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood.
Albertini RJ; Castle KL; Borcherding WR
Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6617-21. PubMed ID: 6983072
[TBL] [Abstract][Full Text] [Related]
8. Hypoxanthine-guanine phosphoribosyltransferase reporter gene mutation for analysis of in vivo clonal amplification in patients with HTLV type 1-associated Myelopathy/Tropical spastic paraparesis.
Albertini RJ; Ardell SK; Judice SA; Jacobson S; Allegretta M
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1747-52. PubMed ID: 11080821
[TBL] [Abstract][Full Text] [Related]
9. The effect of T-lymphocyte 'clonality' on the calculated hprt mutation frequency occurring in vivo in humans.
O'Neill JP; Nicklas JA; Hunter TC; Batson OB; Allegretta M; Falta MT; Branda RF; Albertini RJ
Mutat Res; 1994; 313(2-3):215-25. PubMed ID: 7523907
[TBL] [Abstract][Full Text] [Related]
10. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytes.
Albertini RJ; O'Neill JP; Nicklas JA; Heintz NH; Kelleher PC
Nature; 1985 Jul 25-31; 316(6026):369-71. PubMed ID: 2991767
[TBL] [Abstract][Full Text] [Related]
12. Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient.
Mandruzzato S; Rossi E; Bernardi F; Tosello V; Macino B; Basso G; Chiarion-Sileni V; Rossi CR; Montesco C; Zanovello P
J Immunol; 2002 Oct; 169(7):4017-24. PubMed ID: 12244204
[TBL] [Abstract][Full Text] [Related]
13. Frequent HPRT mutations in paroxysmal nocturnal haemoglobinuria reflect T cell clonal expansion, not genomic instability.
Chen G; Zeng W; Green S; Young NS
Br J Haematol; 2004 May; 125(3):383-91. PubMed ID: 15086421
[TBL] [Abstract][Full Text] [Related]
14. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
Shilyansky J; Nishimura MI; Yannelli JR; Kawakami Y; Jacknin LS; Charmley P; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2829-33. PubMed ID: 7511820
[TBL] [Abstract][Full Text] [Related]
15. Overview of the Germline and Expressed Repertoires of the TRB Genes in
Massari S; Bellini M; Ciccarese S; Antonacci R
Front Immunol; 2018; 9():2526. PubMed ID: 30455691
[TBL] [Abstract][Full Text] [Related]
16. Southern-blot analyses of human T-lymphocyte mutants induced in vitro by gamma-irradiation.
O'Neill JP; Hunter TC; Sullivan LM; Nicklas JA; Albertini RJ
Mutat Res; 1990 Feb; 240(2):143-9. PubMed ID: 2153929
[TBL] [Abstract][Full Text] [Related]
17. Molecular analyses of in vivo hprt mutations in human T-lymphocytes: IV. Studies in newborns.
McGinniss MJ; Nicklas JA; Albertini RJ
Environ Mol Mutagen; 1989; 14(4):229-37. PubMed ID: 2583130
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen.
Cole DJ; Weil DP; Shilyansky J; Custer M; Kawakami Y; Rosenberg SA; Nishimura MI
Cancer Res; 1995 Feb; 55(4):748-52. PubMed ID: 7531614
[TBL] [Abstract][Full Text] [Related]
19. T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines.
Nishimura MI; Custer MC; Schwarz SL; Parker LL; Mixon A; Clay TM; Yannelli JR; Rosenberg SA
J Immunother; 1998 Sep; 21(5):352-62. PubMed ID: 9789197
[TBL] [Abstract][Full Text] [Related]
20. 6-Thioguanine resistant T-lymphocyte determination as a possible indicator of human ionizing radiation exposure.
Ostrosky-Wegman P; Montero R; Cortinas de Nava C; Hurtado F
Bol Estud Med Biol; 1989; 37(3-4):77-81. PubMed ID: 2633789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
